

Phone (Mobile)
+1 651 ❅❅❅ ❅❅❅❅
Phone (Mobile)

Phone (HQ)
(800) 282-2881
Phone (HQ)

Office Address (HQ)
1 Express Way, St. Louis, Missouri, 63121, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Devon Arndt
According to Datanyze information, these are Devon Arndt's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 651 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(800) 282-2881
Phone (HQ)
Office Address (HQ)
1 Express Way, St. Louis, Missouri, 63121, United States
Office Address (HQ)
Devon Arndt works as a Managing Director, Product Innovation at Express Scripts, which is a Business Services company with an estimated 16.5 K employees; and founded in 1986. They are part of the Emerging Technology / Innovation team within the Engineering & Technical Department and their management level is Director. Devon is currently based in St. Louis, United States. They used to work at Takeda and Takeda and have used the following emails: , @takeda.com, @uhc.com.
Wow! Devon seems fun! 😎
Devon Arndt's career began less then a year ago. Prior to joining Express Scripts, Devon worked at 9 companies.
Senior Director, Market Access & Channel Strategy
Senior Director, Corporate Accounts
Director, Business Case Analytics Commercial Analytics & Forecasting
Director, Network Strategies Unitedhealthcare Networks
Associate Director, Pharmacy Analytics Unitedhealthcare Networks
Manager, Healthcare Economics Unitedhealthcare Network
Healthcare Economics Consultant - UnitedHealthcare Network
Community & State Senior Financial Analyst
Financial Analyst & Community & State Intern
Express Scripts
1 Express Way, St. Louis, Missouri, 63121, United States
16.5 K
$3.5 B
Business Services, Management Consulting
Get Full Profile Access
Ice Breakers
Imagine you could know all about Express Scripts - Devon Arndt’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Devon’s company in the news
ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies
December 19, 2024
Kentucky sues Express Scripts, alleging it had a role in the deadly opioid addiction crisis
September 27, 2024
Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formulary
August 29, 2024
See more
Insights to Break the Ice
In your first interaction
Devon is located in United States
Express Scripts’s Funding
Last funding
$92M
January 19, 1992
Total raised
$92M
Work Colleague
See Devon Arndt's coworkers out of Express Scripts's 16.5 K employees